Pseudoxanthoma elasticum future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{SI}} | {{SI}} | ||
{{CMG}}; {{AE}} {{AO}} | {{CMG}}; {{AE}} {{AO}} | ||
==Overview== | ==Overview== | ||
* Magnesium oxide supplements - This is currently being evaluated for its ability to reverse calcium deposits in the skin, and the yellow bumps and folds of skin in patients with pseudoxanthoma elasticum (PXE). | * Magnesium oxide supplements - This is currently being evaluated for its ability to reverse calcium deposits in the skin, and the yellow bumps and folds of skin in patients with pseudoxanthoma elasticum (PXE). | ||
Latest revision as of 13:06, 20 August 2013
Pseudoxanthoma elasticum Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudoxanthoma elasticum future or investigational therapies On the Web |
American Roentgen Ray Society Images of Pseudoxanthoma elasticum future or investigational therapies |
FDA on Pseudoxanthoma elasticum future or investigational therapies |
on Pseudoxanthoma elasticum future or investigational therapies |
Pseudoxanthoma elasticum future or investigational therapies in the news |
Blogs on Pseudoxanthoma elasticum future or investigational therapies |
Risk calculators and risk factors for Pseudoxanthoma elasticum future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
- Magnesium oxide supplements - This is currently being evaluated for its ability to reverse calcium deposits in the skin, and the yellow bumps and folds of skin in patients with pseudoxanthoma elasticum (PXE).